Christopher Peetz
CIK 1614740 · CHIEF EXECUTIVE OFFICER · last filed 2026-07-17
Christopher Peetz is a CHIEF EXECUTIVE OFFICER who has filed 61 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for ARQT, was dated Jul 17, 2026. Across all open-market trades the lifetime net is −$20.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $44.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$44.63M
4
61
-$20.50M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARQT | Director | 191,815 | $25.92 | $4.97M | $0 | 1 | 2026-07-17 |
| MIRM | CHIEF EXECUTIVE OFFICER | 401,809 | $98.70 | $39.66M | -$20.54M | 38 | 2026-07-08 |
| ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted | Director | 0 | $64.97 | $0 | $38.6K | 10 | 2024-05-20 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | Chief Financial Officer | — | — | — | $0 | 3 | 2016-01-14 |
Recent Filings
61 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-17 | ARQT | Grant (A) | +4,315 | $0 | EDGAR |
| 2026-07-08 | MIRM | Mixed | — | -$2.39M | EDGAR |
| 2026-07-06 | MIRM | Notice (144) | −20,000 | -$2.45M | EDGAR |
| 2026-06-02 | MIRM | Mixed | — | -$2.79M | EDGAR |
| 2026-06-01 | MIRM | Notice (144) | −30,000 | -$2.88M | EDGAR |
| 2026-03-17 | MIRM | Mixed | +34,015 | -$3.77M | EDGAR |
| 2026-03-17 | MIRM | Notice (144) | −40,985 | -$3.80M | EDGAR |
| 2026-02-03 | MIRM | Sell (S) | −9,108 | -$940.9K | EDGAR |
| 2026-02-02 | MIRM | Notice (144) | −9,108 | -$945.4K | EDGAR |
| 2026-01-30 | MIRM | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.